Deal facts
- Buyer
- TULIP UK BIDCO LIMITED
- Target
- Spire Healthcare Group plc
- Deal value
- GBP 1,026,500,000
- Announced
- 7 September 2026
- Status
- Firm intention
- Sector
- Healthcare
- Country
- United Kingdom
- Consideration
- cash, loan-note
Sources
TULIP UK BIDCO LIMITED has agreed to acquire Spire Healthcare Group plc in a going private transaction valued at approximately GBP 1.0265 billion. The deal structure involves consideration comprising cash and loan notes, reflecting the equity value of the target company. This acquisition marks a significant shift for the healthcare sector entity, as it moves from public ownership to being taken private by the acquiring vehicle. The announcement was made on 7 September 2026, establishing the timeline for this major corporate restructuring event within the British market.
The transaction is currently at the firm intention stage, indicating that definitive agreements have been reached but final completion has not yet occurred. As a result, the deal remains subject to various customary closing conditions and regulatory approvals before it can be formally concluded. Spire Healthcare Group plc operates within the healthcare industry, providing private medical services across the United Kingdom. The buyer, TULIP UK BIDCO LIMITED, is based in Great Britain, aligning with the target’s domestic operations. This move effectively removes the listed company from public markets, allowing for a new ownership structure focused on long-term strategic development without the pressures of quarterly public reporting requirements.
More M&A Tools
Explore the Toolkit
Tools, frameworks and AI assistants designed for entrepreneurs serious about M&A.
Access nowDeal timeline
1 update- Court sanction
Recommended Offer for Spire Healthcare Group plc
FOR IMMEDIATE RELEASE 5 September 2026 RECOMMENDED ACQUISITION of SPIRE HEALTHCARE GROUP PLC by TULIP UK BIDCO LIMITED (a newly formed company to be indirectly owned by a consortium including (i) funds managed or advised by Toscafund Asset Management LLP; (ii) funds managed or advised by THCP Advisory Limited; and (iii) funds managed or advised by Ares Management Limited) t
LSE RNS
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
Onyx Bidco LLC to acquire Option Care Health, Inc.
Onyx Bidco LLC has agreed to acquire Option Care Health, Inc. in a cash transaction. The deal, announced on 5 October 2026, involves the US-based buyer purchasing the US…
- Buyer
- Onyx Bidco LLC
- Target
- Option Care Health, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Lifecore Inc. to acquire Lifecore Biomedical, Inc.
Lifecore Inc. has agreed to acquire Lifecore Biomedical, Inc. in a transaction designed to take the healthcare company private. The deal was announced on 28 September 20…
- Buyer
- Lifecore Inc.
- Target
- Lifecore Biomedical, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
Curium US Holdings LLC to acquire Lantheus Holdings, Inc.
Curium US Holdings LLC has agreed to acquire Lantheus Holdings, Inc. in a transaction designed to take the healthcare company private. The deal was announced on 3 August…
- Buyer
- Curium US Holdings LLC
- Target
- Lantheus Holdings, Inc.
- Deal value
- Not disclosed
- Deal type
- going private
CCP PAW 2 LIMITED to acquire ANIMALCARE GROUP PLC
CCP PAW 2 Limited has agreed to acquire Animalcare Group Plc in a going private transaction. The deal was announced and completed on 30 July 2026. Both the buyer and the…
- Buyer
- CCP PAW 2 LIMITED
- Target
- ANIMALCARE GROUP PLC
- Deal value
- Not disclosed
- Deal type
- going private
argenx BV to acquire Forte Biosciences, Inc.
argenx BV and Forte Biosciences, Inc. entered the Exit Mode archive.
- Buyer
- argenx BV
- Target
- Forte Biosciences, Inc.
- Deal value
- USD 2,200,000,000
- Deal type
- going private
Buyer history
TULIP UK BIDCO LIMITED
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive